Oklahoma 2025 2025 Regular Session

Oklahoma House Bill HR1005 Introduced / Bill

Filed 02/24/2025

                     
 
Req. No. 12811 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
1st Session of the 60th Legislature (2025) 
 
HOUSE 
RESOLUTION 1005 	By: Sneed 
 
 
 
 
 
AS INTRODUCED 
 
A Resolution recognizing February 26, 2025, as 
Hypertrophic Cardiomyopathy Awareness Day at the 
State Capitol; and expressing the importance of 
Hypertrophic Cardiomyopathy Awareness Day . 
 
 
 
 
 
WHEREAS, hypertrophic cardiomyopathy (HCM) is a chronic cardiac 
disease involving thickening of the heart muscle and can potentially 
lead to debilitating symptoms and serious complications including 
heart failure, atrial fibrillation, stroke, and in rare cases sudden 
cardiac death; and 
WHEREAS, HCM is the most common inheritable heart disease and 
can affect anyone regardless of age, gender, or ethnicity with a 
reported prevalence ranging fro m 1 in 200 to 1 in 500 in the general 
population; and 
WHEREAS, an estimated 700,000 to 1,650,000 people in the United 
States have HCM, yet 85% of them may remain undiagnosed; and 
WHEREAS, HCM shares symptoms with other common cardiovas cular 
and pulmonary diseases, such as shortness of breath, chest pain,   
 
Req. No. 12811 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
fatigue, palpitations, and faintin g, making it difficult to 
distinguish HCM from these other diseases; and 
WHEREAS, when untreated, all-caused mortality risk is 3 to 4 
times higher in patients with HCM than that of the general 
population; and 
WHEREAS, knowing one's medical history and any signs and 
symptoms of HCM is an important first step in receiving an accurate 
diagnosis of HCM; and 
WHEREAS, a health care provider must conduct a thorough 
screening with cardiac health questions to help identify a risk of 
cardiac disorders both genetic an d congenital; and 
WHEREAS, a health care provider may conduct several tests, 
including an echocardiogram, a cardiac MRI, or genetic testing to 
confirm a family history of H CM, and must examine the heart to 
diagnose HCM; and 
WHEREAS, following a diagnosis of HCM, it is important for 
patients to work with their health care provider to learn more about 
their disease and understand different management options, including 
prescription medications and surgical treatment options that may 
help; and 
WHEREAS, the fourth Wednesday in February is an appropriate day 
to observe Hypertrophic Cardiomyopathy Awareness Day. 
NOW, THEREFORE, BE IT RESOLVED BY THE HOUSE OF REPRESENTATIVES 
OF THE 1ST SESSION OF THE 60TH OKLAHOMA LEGISLATURE:   
 
Req. No. 12811 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
THAT the fourth Wednesday, February 26, 2025, is hereby 
recognized by the Oklahoma House of Representatives and the State of 
Oklahoma as Hypertrophic Cardiomyopathy Awareness Day , in order to 
raise public awareness about hypertrophic cardiomyopathy . 
THAT the Oklahoma House of Representatives a cknowledges the 
critical importance of hypertrophic cardiomyopathy awareness to 
improve cardiovascular health in the State of Oklahoma. 
THAT the Oklahoma House of Represent atives supports raising 
awareness of the consequences of undiagnosed and untreated 
hypertrophic cardiomyopathy and the need to seek appropriate care 
for hypertrophic cardiomyopathy as a serious public health issue. 
 
60-1-12811 TJ 02/21/25